Structural analysis of SARS-CoV-2 proofreading enzyme reveals drug resistance mechanisms
Original framing: “'Atomic snapshots' of proofreading enzyme could lead to better COVID-19 drugs” — Phys.org
The study provides high-resolution structural data on the proofreading enzyme, enabling more precise drug design. However, it lacks a systems-level analysis of how viral evolution interacts with human behavior, environmental factors, and global health infrastructure.
The structural analysis of the SARS-CoV-2 proofreading enzyme reveals the virus's adaptive resilience, but this insight must be contextualized within broader systemic challenges.
Integrating structural biology with ecological and social science perspectives can lead to more effective and equitable antiviral strategies. Indigenous and traditional knowledge systems offer valuable insights into holistic health approaches that can complement modern drug development. By embracing interdisciplinary collaboration and centering marginalized voices, we can move beyond the limitations of current biomedical models and build a more resilient global health infrastructure.